Pancreatic Cancer Research

ResearcherEdward HospitalActive in the last 2 years

Fadi S. Dahdaleh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8885-8981; OpenAlex author ID A5038987271. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2021: 4 papers · 2022: 2 papers · 2023: 1 paper · 2024: 2 papers

Papers 9

  1. Comparing oncologic and surgical outcomes of robotic and laparoscopic pancreatoduodenectomy in patients with pancreatic cancer: a propensity-matched analysis. Co-author DOI 10.1007/s00464-024-10783-1↗
  2. Role of minimally invasive surgery in the management of localized pancreatic ductal adenocarcinoma: a review. Last author DOI 10.1007/s11701-024-01825-w↗
  3. The role of minimally invasive surgery in resectable distal pancreatic adenocarcinoma. Co-author DOI 10.1016/j.hpb.2023.06.003↗
  4. Surgical Approach does not Affect Return to Intended Oncologic Therapy Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: A Propensity-Matched St… Last author DOI 10.1245/s10434-022-12347-w↗
  5. ASO Author Reflections: Minimally Invasive Pancreaticoduodenectomy for Pancreatic Cancer: Are We Maximizing Delivery of Multimodality Therapy? Co-author DOI 10.1245/s10434-022-12427-x↗
  6. Neoadjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma is Associated with Lower Post-Pancreatectomy Readmission Rates: A Population-Based Cohort Study. Last author DOI 10.1245/s10434-020-09470-x↗
  7. ASO Author Reflections: Is Neoadjuvant Chemotherapy Associated with Acceptable Short-Term Outcomes for Pancreatic Cancer? First author DOI 10.1245/s10434-020-09472-9↗
  8. Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population… Last author DOI 10.1245/s10434-021-09823-0↗
  9. ASO Author Reflections: Postoperative Chemotherapy After Neoadjuvant Therapy and Pancreatectomy for Pancreatic Cancer: Balancing Patient Physiology and Disease… First author DOI 10.1245/s10434-021-09896-x↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Samer A. Naffouje · 7 shared papers, 2021–2024 · strength 1.58
  2. Sivesh Kathir Kamarajah · 5 shared papers, 2021–2022 · strength 1.12
  3. George I. Salti · 3 shared papers, 2021–2022 · strength 0.56
  4. Jason W. Denbo · 2 shared papers, 2022–2023 · strength 0.38
  5. Toms Augustin · 2 shared papers, 2023–2024 · strength 0.37
  6. Jenny H. Chang · 2 shared papers, 2023–2024 · strength 0.37
  7. Richard Matthew Walsh · 2 shared papers, 2023–2024 · strength 0.37
  8. Kathryn A. Stackhouse · 2 shared papers, 2023–2024 · strength 0.37
  9. Rasha T. Kakati · 1 shared paper, 2024 · strength 0.31
  10. Chase J. Wehrle · 1 shared paper, 2024 · strength 0.20
  11. Kimberly P. Woo · 1 shared paper, 2024 · strength 0.20
  12. Steven Alan White · 1 shared paper, 2021 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.